Dupont Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Dupont Capital Management's HAE Position: Q1 2023 in Review
Dupont Capital Management sold out of Haemonetics (HAE) in Q1 2023, closing a stake of 2,003 shares — an estimated $158K sold.
Dupont Capital Management first reported a position in HAE in Q4 2017 and held it in 21 quarters. The position peaked at $4.54M in Q4 2019. 301 funds tracked by Wall St. Rank hold HAE as of Q1 2023.
- Dupont Capital Management reported no remaining Haemonetics position as of Q1 2023 after selling out during the quarter.
- Dupont Capital Management sold 2,003 Haemonetics shares in Q1 2023, an estimated $158K.
- Dupont Capital Management first reported a position in Haemonetics in Q4 2017 and held it in 21 quarters.
- Dupont Capital Management's Haemonetics position peaked at $4.54M in Q4 2019.
- 301 funds tracked by Wall St. Rank held Haemonetics as of Q1 2023.
Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.